The News Feed

Eyelids

Study Proposes New Prediction Model for Eyelid Sebaceous Carcinoma Recurrence

Outperforming traditional TNM staging, a novel nomogram that incorporates key risk factors may offer clinicians a more precise forecasting tool.
September 6, 2024

Various Chronic Inflammatory Conditions Linked to Involutional Ectropion

Blepharitis and conjunctivitis increased risk three- to fourfold, while systemic factors such as hypertension, dyslipidemia and rheumatic disease conferred a 1.5-fold greater likelihood.
August 6, 2024

Meibomian Gland Morphological Abnormalities Found in Children

Risk factors include elevated body mass index, an unhealthy diet and reduced outdoor activity.
July 8, 2024

New Three-ingredient Eyelid Wipe for Blepharitis Debuts

The eco-friendly product contains Manuka honey, soy protein and purified water in a biodegradable bamboo-based towelette.
May 23, 2024

New Treatment Pairs with BlephEx to Help Restore MG Function

“OptiVize,” as the company calls it, is indicated for monthly use immediately following blepharoexfoliation until meibum health improves.
May 1, 2024

Study: Diabetic Retinopathy Patients Show Greater Incidence of Ptosis

The association was most strongly associated with female sex and older age among the subjects.
March 13, 2024

Strabismus Risk Higher After Lower vs. Upper Blepharoplasty

While still a rare complication—occurring in 1.5% to 2% of surgeries—such cases were more likely to be diagnosed and require intervention within three years, study finds.
February 16, 2024

Common OSSN Therapy May Also Treat Demodex Blepharitis

After two cycles of 1% 5-fluorouracil, patients in a small study experienced clinical improvement lasting up to 55 months.
January 23, 2024

Three Weeks of Azithromycin May Benefit MGD

A recent study demonstrates that this once-a-week course is as effective as six weeks of daily oral doxycycline but with fewer adverse effects.
December 27, 2023

Decompression Outperforms Teprotumumab in Reducing Proptosis

A new study shows surgery had a greater effect on this symptom of thyroid eye disease, yet suggests additional benefits when both treatments are used sequentially.
November 21, 2023